United States Chronic Pain Market Report 2020: Pipeline, Epidemiology, Companies, Drugs, Sales, Shares and More

DUBLIN, Sept. 8, 2020 /PRNewswire/ -- The "US Chronic Pain Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive insights into Chronic Pain pipeline products, Chronic Pain epidemiology, Chronic Pain market valuations and forecast, Chronic Pain drugs sales and competitive landscape in the US.

The research is classified into seven sections - Chronic Pain treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

• Chronic Pain pipeline: Find out the products in clinical trials for the treatment of Chronic Pain by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
• Chronic Pain epidemiology: Find out the number of patients diagnosed (prevalence) with Chronic Pain in the US
• Chronic Pain drugs: Identify key products marketed and prescribed for Chronic Pain in the US, including trade name, molecule name, and company
• Chronic Pain drugs sales: Find out the sales revenues of Chronic Pain drugs in the US
• Chronic Pain market valuations: Find out the market size for Chronic Pain drugs in 2019 in the US. Find out how the market advanced from 2016 and forecast to 2025
• Chronic Pain drugs market share: Find out the market shares for key Chronic Pain drugs in the US

Benefits of this Research

• Support monitoring and reporting national Chronic Pain market analysis and sales trends
• Track competitor drugs sales and market share in the US Chronic Pain market
• Track competitive developments in Chronic Pain market and present key issues and learnings
• Synthesize insights for Chronic Pain market and products to drive business performance
• Answer key business questions about the Chronic Pain market
• Evaluate commercial market opportunity assessment, positioning, and segmentation for Chronic Pain products
• Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Chronic Pain Treatments
2) Chronic Pain Pipeline
3) US Chronic Pain Epidemiology
4) Marketed Drugs for Chronic Pain in US
5) US Chronic Pain Market Size and Forecast
6) US Chronic Pain Products Sales and Forecast
7) US Chronic Pain Market Competitive Landscape
8) Methodology

List of Tables
1. Chronic Pain Phase 3 Clinical Trials, 2020
2. Chronic Pain Phase 2 Clinical Trials, 2020
3. Chronic Pain Phase 1 Clinical Trials, 2020
4. Chronic Pain Epidemiology, US, 2016-2025
5. Marketed Drugs for Chronic Pain, US, 2019
6. Chronic Pain Market Size and Forecast ($), US, 2016-2025
7. Chronic Pain Product Sales ($), US, 2016-2025

List of Figures
1. Chronic Pain Epidemiology, US, 2016-2025
2. Chronic Pain Market Size and Forecast ($), US, 2016-2025
3. Chronic Pain Products Market Share (%), US, 2019

For more information about this report visit https://www.researchandmarkets.com/r/xa7ky3

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/united-states-chronic-pain-market-report-2020-pipeline-epidemiology-companies-drugs-sales-shares-and-more-301125530.html

SOURCE Research and Markets